Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?
JOURNAL OF HEPATOLOGY (2011)
Journal
JOURNAL OF HEPATOLOGY
Volume 54, Issue 4, Pages 835-836Publisher
ELSEVIER SCIENCE BV
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Hepatitis C virus (HCV) seroprevalence, RNA detection, and genotype distribution across Florida, 2015-2018
Brittney L. Dickey, Anna E. Coghill, Julie A. Rathwell, Richard R. Reich, Susan T. Vadaparampil, Shannon M. Christy, Richard Roetzheim, Elizabeth Shenkman, Anna R. Giuliano
PREVENTIVE MEDICINE (2022)
Responsible Inclusion of Pregnant Individuals in Eradicating HCV
Ravi Jhaveri, Lynn M. Yee, Swati Antala, Margaret Murphy, William A. Grobman, Seema K. Shah
HEPATOLOGY (2021)
Vancomycin Soaking Is Highly Cost-Effective in Primary ACLR Infection Prevention: A Cost-Effectiveness Study
Anthony P. Truong, Daniel Perez-Prieto, Joshua Byrnes, Joan C. Monllau, Christopher J. Vertullo
AMERICAN JOURNAL OF SPORTS MEDICINE (2022)
Effective energy management and cost effective day ahead scheduling for distribution system with dynamic market participants*
B. V. Surya Vardhan, Mohan Khedkar, Ishan Srivastava
SUSTAINABLE ENERGY GRIDS & NETWORKS (2022)
Phylogenetic analysis of the 5' untranslated region of HCV from cirrhotic patients in Khyber Pakhtunkhwa, Pakistan
Amin Ullah, Irshad Ur Rehman, Jamshaid Ahmad, Margaret Odenthal, Saad Ahmad, Tariq Nadeem, Qurban Ali, Muhammad Rizwan, Muhammad Ajmal Khan, Said Hassan, Hina Ahsan, Bashir Ahmad
SCIENTIFIC REPORTS (2021)
Sofosbuvir plus Ribavirin is effective for HCV elimination in people living with HIV from rural area of China
Liyu Chen, Lingyao Du, Shuang Kang, Fanghua Ma, Changmin Li, Min He, Lang Bai, Hong Tang
SCIENTIFIC REPORTS (2021)
Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients
Daniel Fuster, David Nunes, Debbie M. Cheng, Richard Saitz, Jeffrey H. Samet
VIRUSES-BASEL (2021)
Elucidating the distinct contributions of miR-122 in the HCV life cycle reveals insights into virion assembly
Marylin Rheault, Sophie E. Cousineau, Danielle R. Fox, Quinn H. Abram, Selena M. Sagan
NUCLEIC ACIDS RESEARCH (2023)
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan
Pin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, Chun-Che Lin, Chun-Yen Lin, Cheng-Yuan Peng, Kuo-Chih Tseng, Ching-Chu Lo, I-Hao Tseng, Chun-Jen Liu
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)
A widely applicable and cost-effective method for specific RNA-protein complex isolation
Sam Balzarini, Roosje Van Ende, Arnout Voet, Koen Geuten
SCIENTIFIC REPORTS (2023)
Guaranteeing Network Reliability to 0-Day Exploits Using Cost-Effective Heterogeneous Node Migration
Yasmany Prieto, Miguel Figueroa, Jorge E. Pezoa
IEEE ACCESS (2022)
The maintenance of microbial community in human fecal samples by a cost effective preservation buffer
Chongming Wu, Tianda Chen, Wenyi Xu, Tingting Zhang, Yuwei Pei, Yanan Yang, Fang Zhang, Hao Guo, Qingshi Wang, Li Wang, Bowen Zhao
SCIENTIFIC REPORTS (2021)
Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis
Jisoo A. Kwon, Georgina M. Chambers, Fabio Luciani, Lei Zhang, Shamin Kinathil, Dennis Kim, Hla-Hla Thein, Willings Botha, Sandra Thompson, Andrew Lloyd, Lorraine Yap, Richard T. Gray, Tony Butler
PLOS ONE (2021)
TRIM26 is a critical host factor for HCV replication and contributes to host tropism
Yisha Liang, Guigen Zhang, Qiheng Li, Lin Han, Xiaoyou Hu, Yu Guo, Wanyin Tao, Xiaomin Zhao, Mingzhe Guo, Tianyu Gan, Yimin Tong, Yongfen Xu, Zhuo Zhou, Qiang Ding, Wensheng Wei, Jin Zhong
SCIENCE ADVANCES (2021)
The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations
Yanfang Huang, Huifen Pan, Qin Gao, Panpan Lv, Xiaoqin Xu, Zhen Zhao
SCIENTIFIC REPORTS (2021)
The HLA-B-21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia
Alexander Hallner, Elin Bernson, Brwa Ali Hussein, Frida Ewald Sander, Mats Brune, Johan Aurelius, Anna Martner, Kristoffer Hellstrand, Fredrik B. Thoren
BLOOD (2019)
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease
Ebru Aydin, Alexander Hallner, Hanna Grauers Wiktorin, Anna Staffas, Kristoffer Hellstrand, Anna Martner
ONCOGENE (2019)
No need to discontinue hepatitis C virus therapy at the time of liver transplantation
Catarina Skoglund, Martin Lagging, Maria Castedal
PLOS ONE (2019)
Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML
Johan Aurelius, Lars Mollgard, Roberta Kiffin, Frida Ewald Sander, Staffan Nilsson, Fredrik Bergh Thoren, Kristoffer Hellstrand, Anna Martner
LEUKEMIA & LYMPHOMA (2019)
Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study
Jonas Soderholm, Aylin Yilmaz, Anders Svenningsson, Katharina Busch, Rune Wejstal, Alma Brolund, Jan Kovamees, Matti Sallberg, Martin Lagging, Magnus Gisslen
JOURNAL OF NEUROLOGY (2019)
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
Malin S. Nilsson, Alexander Hallner, Mats Brune, Staffan Nilsson, Fredrik B. Thoren, Anna Martner, Kristoffer Hellstrand
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia
Malin S. Nilsson, Alexander Hallner, Mats Brune, Staffan Nilsson, Fredrik B. Thoren, Anna Martner, Kristoffer Hellstrand
BRITISH JOURNAL OF HAEMATOLOGY (2020)
The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection
Jesper Waldenstrom, Kristina Nystrom, Staffan Nilsson, Gunnar Norkrans, Magdalena Ydreborg, Nina Langeland, Kristine Morch, Johan Westin, Martin Lagging
PLOS ONE (2020)
Presence of interferon-λ, 4, male vender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus
Jesper Waldenstrom, Kristoffer Hellstrand, Johan Westin, Staffan Nilsson, Peer Christensen, Martti Farkkila, Kristine Morch, Nina Langeland, Gunnar Norkrans, Martin Lagging
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection
Jesper Waldenstrom, Martin Kaberg, Marianne Alanko Blome, Anders Widell, Per Bjorkman, Staffan Nilsson, Anders Hammarberg, Ola Weiland, Kristina Nystrom, Martin Lagging
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
Impact of CYBA genotypes on severity and progression of multiple sclerosis
Andreas Tornell, Roberta Kiffin, Sara Haghighi, Natalia Mossberg, Oluf Andersen, Kristoffer Hellstrand, Anna Martner
EUROPEAN JOURNAL OF NEUROLOGY (2022)
Transient and durable T cell reactivity after COVID-19
Anna Martner, Hanna Grauers Wiktorin, Andreas Tornell, Johan Ringlander, Mohammad Arabpour, Magnus Lindh, Martin Lagging, Staffan Nilsson, Kristoffer Hellstrand
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Catch-up antibody responses and hybrid immunity in mRNA vaccinated patients at risk of severe COVID-19
Samer Al-Dury, Jesper Waldenstrom, Johan Ringlander, Sigrun Einarsdottir, Markus Andersson, Hevar Hamah Saed, Johan Waern, Anna Martner, Kristoffer Hellstrand, Martin Lagging
INFECTIOUS DISEASES (2023)